| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | -0.075 | 0.03 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | 0.082 | 0.03 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | -0.11 | 0.03 |
| mRNA | FR-180204 | GDSC1000 | pan-cancer | AAC | -0.072 | 0.03 |
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | -0.11 | 0.04 |
| mRNA | cyanoquinoline 11 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.04 |
| mRNA | HG-5-88-01 | GDSC1000 | pan-cancer | AAC | -0.092 | 0.04 |
| mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | -0.078 | 0.04 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | 0.068 | 0.05 |
| mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | -0.062 | 0.05 |